Ex vivo expansion CD34+/AC133+-selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy. [electronic resource]
Producer: 19990929Description: 105-12 p. digitalISSN:- 1269-3286
- AC133 Antigen
- Adult
- Antigens, CD
- Antigens, CD34 -- blood
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Cell Division -- drug effects
- Cyclophosphamide -- administration & dosage
- Epirubicin -- administration & dosage
- Female
- Glycoproteins -- blood
- Hematopoietic Stem Cells -- cytology
- Humans
- Injections, Subcutaneous
- Interleukin-11 -- pharmacology
- Interleukin-3 -- pharmacology
- Middle Aged
- Peptides -- blood
- Stem Cell Factor -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.